The phrase "availability of the compound" is correct and usable in written English.
It can be used in scientific or technical contexts when discussing whether a specific compound can be accessed or obtained.
Example: "The availability of the compound is crucial for the success of the experiment."
Alternatives: "accessibility of the compound" or "readiness of the compound".
The selection of either DOTATATE or DOTATOC for imaging was purely based on the availability of the compound due to patent regulations.
Despite the very promising clinical results of F-FAMT, existing methods for synthesizing F-FAMT produce a low chemical yield, which limits the availability of the compound for clinical use, and they require high-performance liquid chromatography (HPLC) for purification, which precludes the use of an automated module to synthesize F-FAMT.
However, in the majority of MoS calculations, this dermal exposure figure is compared to an oral NOAEL value, which corresponds to the amount that has been administered orally, though not necessarily to the actual systemic availability of the compound after oral administration.
The simplest method, due to the availability of the compounds, is to add 4-methylpropiophenone dissolved in glacial acetic acid to bromine, creating an oil fraction of 4'-methyl-2-bromopropiophenone.
This easy availability of the compounds has resulted in a gradual increase in accidental and suicidal poisoning, mainly in developing countries [ 10].
If this block is occurring, the lycopene could accumulate in immature seeds increasing the availability of this compound for the bixin pathway.
Another para-hydroxylated metabolite, 4-HO-BDE-42, appears to have been more potent than DE-71, but because of limited availability of this compound, the analysis was not carried out with a sufficient span of concentrations to allow an accurate estimate of the EC50.
However, to date, the availability of this compound is not sufficient to satisfy the commercial requirements.
32 While the oral availability of this compound is an attractive property for chronic administration, challenges to optimal therapeutic efficacy remain, including the inability of ABT-737 and ABT-263 to inhibit MCL-1 and the common incidence of thrombocytopenia as a result of potent BCL-XL inhibition in platelets.
Generally PCBs do not bind to the sex hormone binding globulin (SHBG) or at very low affinity [ 18], which may cause a higher bio-availability of the compounds.
This preserves unmetabolized OXY in the circulation and results in greater systemic availability of the parent compound.
